Barclays’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.75K | Buy |
|
|||||
|
2025
Q2 | $0 | Hold |
|
|||||
|
2025
Q1 | $0 | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $28K | Sell |
|
|||||
|
2021
Q4 | $341K | Sell |
|
|||||
|
2021
Q3 | $564K | Sell |
|
|||||
|
2021
Q2 | $802K | Sell |
|
|||||
|
2021
Q1 | $1.06M | Buy |
|
|||||
|
2020
Q4 | $589K | Buy |
|
|||||
|
2020
Q3 | $197K | Sell |
|
|||||
|
2020
Q2 | $289K | Buy |
|
|||||
|
2020
Q1 | $179K | Sell |
|
|||||
|
2019
Q4 | $452K | Buy |
|
|||||
|
2019
Q3 | $196K | Sell |
|
|||||
|
2019
Q2 | $397K | Sell |
|
|||||
|
2019
Q1 | $434K | Buy |
|
|||||
|
2018
Q4 | $26K | Sell |
|
|||||
|
2018
Q3 | $321K | Sell |
|
|||||
|
2018
Q2 | $411K | Buy |
|
|||||
|
2018
Q1 | $457K | Sell |
|
|||||
|
2017
Q4 | $441K | Sell |
|
|||||
|
2017
Q3 | $497K | Buy |
|
|||||
|
2017
Q2 | $142K | Sell |
|
|||||
|
2017
Q1 | $221K | Buy |
|
|||||
|
2016
Q4 | $3K | Sell |
|
|||||
|
2016
Q3 | $5K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $3K | Buy |
|